Table 3.
Extent of resection (EOR), contrast enhanced residual tumor volume (CERTV), biological tumor volume (BTV), and SUVmax correlations.
| GTR | STR | PR | |
|---|---|---|---|
| No patients | 45 | 18 | 16 |
| Residual Tumor NO (CERTV/BTV) | 15 | 0 | 0 |
| Residual Tumor YES CERTV + BTV |
15 | 18 | 16 |
| BTV only | 15 | 0 | 0 |
| Median SUVmax (range) | 3.70 (2.20–9.54) | 3.25 (2.3–7.5) | 4.7 (2.96–9.30) |
| Median PFS months (range) | 10 (6–22) | 11 (2–28) | 10 (2–35) |
GTR—gross total resection: 95–100%; STR—subtotal resection: 78–95%; PR—partial resection: 30–77%; CERTV—contrast enhanced residual tumor volume; BTV—biological tumor volume.